Strong Pills Warning EU - IKEA

'An 18-year-old man has died in Jersey, after taking "strong" ecstasy tablets. Kyle Pringle was taken to the General Hospital, but died there just before 6:30am on Saturday. Police say "the evidence suggests" Kyle's death was caused by consuming IKEA branded tablets. Officers had put out a warning about the tablets over the weekend, claiming they are "stronger than expected".'

http://www.itv.com/news/channel/2017-06-19/eighteen-year-old-dies-after-taking-strong-ecstasy-in-jersey/

• Posted by johnboy
• June 21, 2017

Mix of 25C-NBOMe, 4-FA and MDMA sold as MDMA in Melbourne AUS

tl;dr NBOMe mixtures sold as MDMA are around, don’t snort unknown caps, use test-kits wisely, look after your mates, and get your lab student/worker friends to contact us so we don’t need to rely on labs in Barcelona to access high-quality drug testing in Australia!

On the weekend 15-16 January 2017, there was a spate of poisonings, hospitalisations and deaths that have been associated a batch of capsules that were reportedly sold as MDMA or Ecstasy. Punters at Revolver nightclub and other clubs on Melbourne’s Chapel Street were affected.

The contents of these caps appeared damp, more like a brown sugar consistency than crystals or powder.

We obtained anonymous reports from people who consumed these capsules. The reports describe very strong hallucinogenic symptoms and paranoia. While in most cases, the symptoms resolved without medical intervention, they were very unpleasant, with one person reporting that they ‘felt like they were going to die or never be the same again’.

Reagent test kit results were shared by Bernie Maitri: these reports showed the substance was unlikely to be MDMA-like, and could instead contain PM(M)A or 2C-T-X. However these results were inconclusive, so we arranged to send a sample of this drug to Barcelona, where Energy Control conducts an international testing service. Mireia Ventura conducted the tests with GC/MS and LC/MS. The testing confirmed that the contents of the capsules:

- 4-FA (main substance)
- a low amount of MDMA
- 25C-NBOMe

This mixture is consistent with the reports. 25C-NBOMe is highly potent with only microgram doses required to produce strong hallucinogenic effects. 4-FA is an amphetamine-type stimulant which has been described as having an effect somewhere between amphetamine and MDMA. It is concerning that a low amount of MDMA was detected in the mixture, as this may be an indication that the manufacturers were hoping to fool reagent test kits by including enough MDMA to produce a positive result.

PLEASE GO TO BLUELIGHT FOR THE REST OF THIS ARTICLE

http://bluelight.org/vb/content/252-25C-NBOMe-4-FA-and-MDMA-mixture

• Posted by johnboy
• February 3, 2017

HOW TO RATE REPORTS

***PLEASE NOTE***

When rating a report (thumbs up/thumbs down), you are rating the QUALITY OF THE REPORT - *NOT* THE PILL!!

Thanks!
PR Admin Team & Mods.

• Posted by ravenousblonde
• October 25, 2009

Understanding Hyaluronic Acid Concentrations in Dermal Fillers: A Technical Gui

Hyaluronic acid has become the dominant molecule in aesthetic injectables, with the vast majority of dermal fillers on the market today based on HA formulations. Yet many practitioners lack deep understanding of how HA concentration, molecular weight, cross-linking density, and other technical parameters influence clinical performance. This knowledge gap can lead to suboptimal product selection, unexpected treatment outcomes, and missed opportunities to achieve superior results. Understanding the science behind HA fillers enables more informed product selection, better matching of products to specific treatment goals, improved technique optimization, and more accurate patient education about expected outcomes.

The Fundamentals of Hyaluronic Acid Chemistry

Hyaluronic acid is a naturally occurring glycosaminoglycan found throughout the human body, particularly abundant in skin, joints, and connective tissues. Its molecular structure consists of repeating disaccharide units forming long polymer chains that can contain thousands of individual sugar molecules. In its native uncross-linked form, hyaluronic acid has a relatively short residence time in tissue, typically degrading within days due to enzymatic breakdown by hyaluronidase and free radical degradation.

The key innovation enabling HA use as a long-lasting dermal filler was the development of cross-linking technology. Cross-linking creates chemical bonds between separate HA polymer chains, forming a three-dimensional gel network that resists enzymatic degradation and mechanical stress. This cross-linked structure persists in tissue for months rather than days, making it suitable for aesthetic applications. However, cross-linking also fundamentally alters the material properties of the HA gel in ways that significantly impact clinical performance.

Different manufacturers have developed proprietary cross-linking technologies that create gels with distinct characteristics. The specific cross-linking chemistry, cross-linking density, molecular weight of the starting HA, and manufacturing processes all contribute to the final product's performance profile. Understanding these technical variables helps practitioners appreciate why different HA fillers with similar stated concentrations can behave quite differently in clinical use.

HA Concentration: What the Numbers Actually Mean

When manufacturers specify HA concentration as a percentage or in milligrams per milliliter, they're describing the total amount of hyaluronic acid present in the gel, typically ranging from 20-30 mg/mL for most aesthetic fillers. A 20 mg/mL filler contains 2% HA by weight, while a 26 mg/mL product contains 2.6%. These numbers might suggest that higher concentrations automatically deliver superior performance, but the relationship between HA concentration and clinical outcomes is more nuanced than simple more-is-better logic.

Higher HA concentration generally contributes to increased gel viscosity and resistance to deformation, greater lifting capacity for volume restoration, potentially longer duration due to more material to degrade, and higher water-binding capacity that can increase swelling. However, higher concentration can also mean increased stiffness that may be inappropriate for delicate areas, more pronounced swelling, particularly in the initial post-treatment period, higher cost per syringe that affects treatment economics, and potentially more challenging injection requiring greater force.

The key insight is that HA concentration represents just one variable in a complex equation determining clinical performance. Two fillers with identical HA concentrations but different cross-linking technologies can exhibit dramatically different behavior. Similarly, a lower concentration filler with optimized cross-linking might outperform a higher concentration product with less sophisticated formulation. Practitioners should evaluate products holistically rather than focusing exclusively on concentration numbers.

Cross-Linking Density and Its Clinical Implications

Cross-linking density refers to how many cross-linking bonds exist within the gel network, typically expressed as a percentage of available binding sites that have been cross-linked. Low cross-linking density creates softer, more pliable gels that integrate smoothly with tissue, spread more easily during injection, create less palpable lumps, and degrade more quickly due to less resistance to enzymatic breakdown. High cross-linking density produces firmer, more cohesive gels that provide stronger structural support, maintain their shape more effectively, last longer in tissue, and require more force during injection.

The optimal cross-linking density depends entirely on the intended application. For fine lines around the mouth or eyes, low to moderate cross-linking density works best, allowing the filler to integrate smoothly without creating visible or palpable irregularities. For cheek augmentation or jawline contouring, moderate to high cross-linking density provides the structural support needed to achieve visible enhancement. For deep volumizing applications like chin augmentation, high cross-linking density delivers the projection and longevity desired.

Manufacturers often create product portfolios with varying cross-linking densities to address different treatment indications. Understanding this allows practitioners to select products that match their specific treatment goals rather than trying to use a single product for all applications. Working with an aesthetic industry supplier that offers comprehensive product lines from multiple manufacturers gives practitioners access to the full spectrum of cross-linking densities needed for diverse treatment scenarios.

Particle Size and Gel Technology Variations

Beyond concentration and cross-linking, the physical structure of HA gels varies significantly across products. Monophasic gels feature a smooth, uniform consistency throughout with no distinct particles, created by homogenizing cross-linked HA into a cohesive gel. These products typically offer smooth injection feel, even distribution in tissue, less granularity or lumpiness, and potentially more predictable spreading. Biphasic or particulate gels contain distinct particles of cross-linked HA suspended in non-cross-linked HA carrier gel, which may provide longer duration as particles degrade more slowly, potentially greater lifting capacity from particle structure, and different tactile characteristics during injection.

Some manufacturers have developed hybrid technologies that combine elements of both approaches, seeking to optimize the advantages of each while minimizing disadvantages. These innovations continue to evolve as manufacturers refine their formulation technologies and respond to practitioner feedback about clinical performance.

Particle size in biphasic gels ranges from very fine particles suitable for superficial injection to large particles designed for deep volumizing. The particle size distribution affects injection characteristics, with smaller particles generally flowing more easily through fine needles while larger particles may require larger gauge needles or cannulas. Clinical performance also varies with particle size, as finer particles integrate more smoothly for superficial applications while larger particles provide more structural support for deep augmentation.

Cohesivity, Elasticity, and G-Prime: Advanced Performance Parameters

Advanced practitioners often consider rheological parameters that describe how gels behave under stress. Cohesivity refers to the gel's tendency to maintain its structure and resist fragmentation during injection and after placement. Highly cohesive gels project more strongly and maintain defined contours, while less cohesive products spread more readily and integrate more smoothly. Cohesivity affects injection technique requirements, as highly cohesive gels often perform best with specific placement techniques that take advantage of their structural properties.

Elasticity describes the gel's ability to deform under stress and then return to its original shape. Elastic gels adapt to facial movement, maintaining natural appearance during animation. They resist permanent deformation from external pressure like sleeping position or massage. Recovery from mechanical stress helps products maintain effectiveness over time. And dynamic areas like lips benefit particularly from elastic formulations that move naturally with facial expression.

G-prime (elastic modulus) quantifies the gel's stiffness and resistance to deformation, measured in Pascals. Higher G-prime indicates firmer gel that provides more structural support, resists compression and maintains projection, and potentially lasts longer before degradation. Lower G-prime suggests softer gel that integrates more naturally in delicate areas, creates less palpability risk, and adapts better to dynamic tissue movement. Different manufacturers emphasize different rheological profiles based on their technology and target applications.

• Posted by pradmin
• March 28, 2026

GLP-1 Gummy Supplements Review: Hype or Helpful for Appetite Control and Metabo

Ozempic and Wegovy rewrote the weight-loss playbook, but demand has led to month-long shortages and four-figure price tags. Prescriptions for GLP-1 drugs jumped 700 percent from 2019 to 2023, and analysts value the market at $100 billion by 2030.

That buzz has spilled into the supplement aisle. Brands—from legacy vitamin houses to newcomers like Asuno’s GLP-1 gummies—now promise the same hunger-taming power in a chewable square.

So, are these sweets a smart shortcut or slick marketing? Over the next few minutes we’ll unpack the science, ingredients, real-world reviews, and safety signals so you can decide with confidence.

What GLP-1 actually does inside your body

GLP-1: your built-in appetite brake

When you start eating, cells that line your small intestine release a messenger called glucagon-like peptide-1 (GLP-1). Picture it as a traffic signal shifting from green to yellow: it tells your stomach to slow the flow of food, nudges the pancreas to send out insulin, and whispers to your brain, “hey, we’re getting full.”

These three signals sync up. A slower stomach keeps you satisfied longer, steady insulin keeps blood sugar level instead of spiking, and the brain cue tempers the urge for seconds. In practical terms, GLP-1 helps you stop eating sooner and enjoy a smooth energy curve instead of a sugar-crash roller-coaster.

That natural loop explains why drug makers copied it. They created GLP-1 receptor agonist injections that amplify the same fullness signal, only much louder. We will cover those shots next and then see why gummies try to tap the pathway without a prescription.

GLP-1 drugs: powerful, pricey, and not for everyone

Drugmakers amplified that natural fullness signal and packaged it in weekly injections such as semaglutide (Ozempic, Wegovy). Clinical trials show participants losing 10 to 15 percent of body weight in one year—results few diet-and-exercise plans match. Blood sugar steadies, cravings ease, and many users say they feel “comfortably indifferent” to junk food.

The catch: each pen costs more than $1,000 a month without insurance, and demand often outpaces supply. Even when you secure a prescription, common side effects include nausea, stomach upset, and occasional severe vomiting. Some people stop early because every meal feels like work.

These access hurdles split the field—potent therapy on one side, a large group priced out or needle-averse on the other. That gap sparked over-the-counter “GLP-1 support” products. Where prescriptions slam the appetite brake, supplements aim to tap it gently: same route, slower car, no clinic visit.

Emergence of GLP-1 gummy supplements: fad or future?

From injections to edibles

When Ozempic pens became scarce, supplement formulators spotted an opening. If people cannot get the shot, or prefer to avoid needles, why not hand them a chewable that sends the same “feel full” signal?

Within months, “GLP-1 support” gummies showed up on pharmacy endcaps, Instagram reels, and late-night TV. Labels promise to “boost fullness hormones” or “support healthy metabolism,” while steering clear of disease-treatment claims. The pitch is simple: trade a needle for a piece of candy, skip the prescription, and keep that social-media weight-loss glow.

The idea feels almost too neat, which partly explains the frenzy. Convenience meets cultural buzz around GLP-1 science, creating a product category that sits between multivitamins and medicine, popular enough to crowd Amazon search results yet still new enough that many clinicians raise an eyebrow.

For a real-world label you can inspect, the GLP-1 gummies sold at https://asuno.com list 3 g of inulin fiber and 500 mg of berberine per serving. Their FAQ also notes that each batch is rigorously tested to confirm potency and purity.

Knowing a brand posts clear milligram counts and spells out its testing standards helps shoppers separate science-backed formulas from candy-coated hype.

How GLP-1 gummies say they work

Nudging the same appetite pathway, just more gently

A gummy never contains actual GLP-1. Instead, formulators pack it with fibers, plant alkaloids, and blood-sugar helpers that aim at the same satiety circuit we covered earlier.

- Soluble fibers swell and ferment in the gut, prompting GLP-1-secreting L-cells to release a little more hormone.

- Mild gastric “brakes” such as apple cider vinegar slow how fast food leaves your stomach, extending the fullness signal.

- Insulin sensitizers, including berberine or chromium, steady post-meal glucose so your brain avoids a spike-and-crash loop.

- Mood or craving modulators like saffron or 5-HTP work higher up the chain, nudging neurotransmitters that govern appetite.

Together, the goal is modest: feel full sooner and keep blood sugar cruising smoothly. The effect is incremental, yet that small dial-turn helps some people snack less without feeling deprived.

Evidence versus exaggeration

The science behind these ingredients whispers more than it shouts. In one small Nutrition Research study, volunteers who added resistant maltodextrin fiber doubled post-meal GLP-1, an encouraging bump but nowhere near the surge from a semaglutide injection.

Berberine shows a similar pattern. Meta-analyses link the alkaloid to a two- to five-pound weight drop over three months, solid for a plant extract but modest next to prescription results. Cinnamon, chromium, and apple cider vinegar rank even lighter; their best data show smoother glucose curves, not dramatic scale changes.

Taken together, gummies offer incremental help. Manage expectations and pair them with protein-forward meals, daily movement, and solid sleep for the best payoff.

What’s inside a GLP-1 gummy?

Soluble fibers: the bulky backbone

Flip any “GLP-1 support” label and you will likely see fiber listed first. Inulin, resistant dextrin, or glucomannan turn each gummy into a plant-based sponge that soaks up water and swells in your gut. That expansion does two things.

First, it stretches the stomach wall just enough to trigger mechanical satiety signals, helping you feel full sooner. Second, the fiber ferments lower in the intestine, prompting L-cells to release a trickle of extra GLP-1. In one study, volunteers who added five grams of resistant maltodextrin saw post-meal GLP-1 roughly double.

Fiber also slows carbohydrate absorption, smoothing blood-sugar peaks that can spark snack hunts. Start slow: one to two grams per gummy allows your digestive tract to adapt without bloating.

Bottom line: quality gummies list at least three grams of soluble fiber per serving. If fiber hides inside a proprietary blend, expect pocket-change results.

Berberine: nature’s Ozempic or just buzz

Berberine, a bright-yellow plant alkaloid, earns plenty of TikTok love. It improves insulin sensitivity and nudges gut hormones, including a modest bump in GLP-1. Meta-analyses covering roughly 1,000 participants show average weight loss of two to five pounds over three months—meaningful support, yet miles from prescription strength.

Safe use clusters around 500–1,000 milligrams a day. Higher doses can cause mild nausea or diarrhea, and anyone pregnant, breastfeeding, or taking glucose-lowering drugs should skip it.

Look for a clear milligram count and third-party purity tests; avoid mystery blends.

Chromium: the quiet glucose chaperone

Chromium picolinate rarely trends, but it helps insulin ferry glucose into muscle cells, steadying energy and appetite. Clinical studies use 200–1,000 micrograms daily and report fewer high-fat cravings plus modest drops in fasting glucose. Effects are subtle, yet the mineral is well-tolerated at label doses.

Ensure your gummy lists at least 200 micrograms; combining it with a multivitamin that already supplies chromium may be unnecessary.

Cinnamon and bitter melon: traditional sugar tamers

Cinnamon’s polyphenols boost insulin-receptor activity, while bitter melon’s charantin and polypeptide-p mimic insulin in lab models. Small trials show two teaspoons of cinnamon powder or its extract equivalent can trim fasting glucose by 10–24 points; bitter-melon capsules deliver similar numbers.

You will not feel an instant craving switch, but steadier glucose curves cut mid-afternoon munchies. Effective servings start at 250 milligrams of cinnamon extract or 50 milligrams of bitter-melon extract. Clear labeling matters.

Apple cider vinegar: trendy but dose-dependent

ACV’s acetic acid slows gastric emptying. In liquid form, one tablespoon before a high-carb meal dropped glucose spikes and prolonged satiety by about 30 percent. A gummy, however, often contains just 500 milligrams of dried ACV—roughly one-tenth of the tested liquid dose.

Powdered ACV avoids enamel wear yet plays a supporting role. Choose gummies that disclose the milligrams and pair them with fiber for a one-two fullness punch.

Probiotics: recruiting friendly gut bacteria

Some premium gummies go beyond vitamins and fiber by adding specific probiotic strains, most notably Akkermansia muciniphila. Low levels of this bacterium correlate with poor metabolic health, and early capsule studies showed a small rise in GLP-1 along with improved insulin sensitivity.

Why does a microbe matter? A. muciniphila lives on the mucus layer that lines the gut wall. Higher counts thicken that layer, reduce inflammation, and help hormone-secreting L-cells work efficiently. Picture it as upgrading the factory floor so GLP-1 signals move without friction.

Delivery is the hurdle. Live bacteria dislike heat, moisture, and oxygen, all common during shipping. Reputable brands use spore-form strains or micro-encapsulation to keep cells viable through shelf life and post third-party lab results to prove it. Without that data, “probiotic” is marketing gloss.

Check the label for a clear CFU count and the strain’s full scientific name. Effective doses start around one billion CFU per day. While that will not rebuild your microbiome overnight, it can smooth digestion and give satiety signals a gentle lift.

Real users’ experiences: wins, let-downs, and everything between

Scroll through Reddit threads or TikTok stitches and you will meet two main camps. The first gushes that a GLP-1 gummy “took the edge off” mindless snacking. Users describe pushing away half-finished dinners or walking past vending machines without that magnetic pull. Reported weight shifts stay small—about two or three pounds in a month—but feel earned rather than forced, which keeps morale high.

The second camp is blunt: “overpriced gummy bears.” These reviewers chewed faithfully for six weeks, felt no change, and logged mild bloating as the only side effect. Their verdict leans toward marketing over substance.

A quieter third group lands in the middle. They pair a solid formula with higher protein and daily walks, then report steadier energy and fewer late-night fridge raids. For them, the gummy serves as a nudge, not an engine.

Taken together, the chatter reinforces a simple truth. Biology, ingredient dose, and daily habits decide who benefits and who writes a one-star review. Gummies are teammates at best. Give them supporting players—balanced meals, movement, and sleep—and they can help you win a few possessions.

Safety, legality, and the fine print

Supplements, not drugs: and the FDA cares

Every GLP-1 gummy falls under the Dietary Supplement Health and Education Act, so labels cannot claim to treat obesity or work “just like Ozempic.” Cross that line and the Food and Drug Administration steps in. To date, the agency has issued one GLP-1–related warning letter—December 10, 2024—to a company that compared its drops to prescription drugs and called them “FDA-approved.” Regulators called the marketing “false and misleading” and ordered a fix.

A single warning does not mean a free pass. The FDA keeps close watch on weight-loss supplements because hidden stimulants and spiked drugs appear every year. If a label promises overnight results or reads like a pharmacy ad, skip it.

Ingredient safety: who should pause before they chew

Most GLP-1 gummy ingredients are safe for healthy adults, yet two groups should read labels twice.

- Pregnancy and nursing. Berberine crosses the placenta and, in animal studies, interferes with bilirubin clearance in newborns. Wait until breastfeeding ends before taking a berberine-based gummy.

- Blood-sugar medication users. Chromium, berberine, and bitter melon all lower glucose. Combine them with metformin or insulin and you risk hypoglycemia. Consult your clinician and use a finger-stick meter to confirm the combo plays nice.

Even if you avoid these flags, ease in. High-fiber formulas swell fast. Start with half a serving for three to five days and let your gut adapt.

How to pick a trustworthy GLP-1 gummy

Look for real doses and clear labels

Start with the numbers. A reputable brand treats its Supplement Facts panel like a résumé—specific and verifiable. Look for at least three grams of soluble fiber and 500 milligrams of berberine per serving if included. Anything less is window dressing.

Transparency matters just as much as totals. Companies that believe in their formula post batch-specific Certificates of Analysis (COA) from an independent lab. No COA, no deal. Skip products that shout “doctor recommended” yet hide doses; that mismatch tells you marketing outranks science.

Verify third-party testing and brand reputation

Numbers mean little if the powder in the gummy does not match the label. Reputable companies hire ISO-accredited labs to screen every batch for potency, heavy metals, and microbes, then publish the COA for easy download. While you are on the brand’s site, check the tone. Do they cite studies, explain ingredient choices, and admit limitations? Or do they promise you will “lose thirty pounds fast” and rely on celebrity selfies?

Scan independent reviews too. A few digestion complaints are normal for high-fiber supplements; dozens hint at a formulation flaw. Consistent praise for appetite control plus transparent labeling is the sweet spot.

Balance cost against what you actually get

Prices swing from twelve to sixty dollars a bottle. Bargain options often cut corners—one gram of fiber, trace botanicals, no testing—so you pay less and receive less. Premium formulas bundle research-level fiber, berberine, and a probiotic, effectively replacing three separate supplements. When you divide cost by effective servings, a forty-dollar bottle can be cheaper per active gram than the bargain brand.

Run a quick value check: What is the monthly cost per clinical dose of fiber or berberine? If a label forces you to triple-chew to reach study levels, multiply the price by three. The “deal” may disappear.

Choose a product that fits your budget and delivers research-backed levels. Paying for candy coloring adds nothing to your satiety score.

Conclusion: gentle boost, not silver bullet

GLP-1 gummies work as allies, not saviors. A quality formula can give you a mild appetite edge, steadier energy, and a nudge to keep portions honest. They will not match the double-digit weight loss seen with prescription injections, and any brand that claims otherwise deserves a hard pass.

Chew strategically. Choose a product with study-level fiber, clearly listed actives, and a posted lab test. Pair it with protein-rich meals, regular movement, and solid sleep. Track hunger cues for four weeks, then judge progress against your own baseline, not social-media before-and-afters.

The right gummy helps tap the brakes on overeating; it does not steer the car. Keep both hands on balanced nutrition, daily activity, and realistic goals, and let the supplement ride shotgun.

• Posted by pradmin
• March 12, 2026